ATE183644T1 - Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden - Google Patents

Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden

Info

Publication number: ATE183644T1
Authority: AT; Austria
Prior art keywords: therapy; prevention; lercanidipine; atherosclerotic; dihydropyridine derivatives
Prior art date: 1995-07-14

Application number

AT96924834T

Other languages

English (en)

Inventor

Abraham Sartani

Amedeo Leonardi

Rodolfo Testa

Original Assignee

Recordati Chem Pharm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-14

Filing date

1996-06-28

Publication date

1999-09-15

1996-06-28 Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm

1999-09-15 Application granted granted Critical

1999-09-15 Publication of ATE183644T1 publication Critical patent/ATE183644T1/de

Links

YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title abstract 3
230000003143 atherosclerotic effect Effects 0.000 title abstract 3
210000001367 artery Anatomy 0.000 title 1
230000007850 degeneration Effects 0.000 title 1
230000002265 prevention Effects 0.000 title 1
238000002560 therapeutic procedure Methods 0.000 title 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
ZDXUKAKRHYTAKV-MGBGTMOVSA-N 5-o-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-o-methyl (4r)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound C1([C@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=CC([N+]([O-])=O)=C1 ZDXUKAKRHYTAKV-MGBGTMOVSA-N 0.000 abstract 1
ZDXUKAKRHYTAKV-XIFFEERXSA-N 5-o-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-o-methyl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound C1([C@@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=CC([N+]([O-])=O)=C1 ZDXUKAKRHYTAKV-XIFFEERXSA-N 0.000 abstract 1
102000007330 LDL Lipoproteins Human genes 0.000 abstract 1
108010007622 LDL Lipoproteins Proteins 0.000 abstract 1
230000015556 catabolic process Effects 0.000 abstract 1
238000006731 degradation reaction Methods 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
ZDXUKAKRHYTAKV-UHFFFAOYSA-N lercanidipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZDXUKAKRHYTAKV-UHFFFAOYSA-N 0.000 abstract 1
229960004294 lercanidipine Drugs 0.000 abstract 1
210000002540 macrophage Anatomy 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000004060 metabolic process Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
238000013508 migration Methods 0.000 abstract 1
230000005012 migration Effects 0.000 abstract 1
238000012986 modification Methods 0.000 abstract 1
230000004048 modification Effects 0.000 abstract 1
210000000107 myocyte Anatomy 0.000 abstract 1
230000001590 oxidative effect Effects 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1
231100000216 vascular lesion Toxicity 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
General Chemical & Material Sciences (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)

AT96924834T 1995-07-14 1996-06-28 Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden ATE183644T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITMI951513A IT1275532B (it)	1995-07-14	1995-07-14	Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa

Publications (1)

Publication Number	Publication Date
ATE183644T1 true ATE183644T1 (de)	1999-09-15

Family

ID=11371972

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96924834T ATE183644T1 (de)	1995-07-14	1996-06-28	Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden

Country Status (19)

Country	Link
EP (1)	EP0839036B1 (de)
JP (1)	JPH11509214A (de)
KR (1)	KR19990028741A (de)
CN (1)	CN1190345A (de)
AT (1)	ATE183644T1 (de)
AU (1)	AU690471B2 (de)
CA (1)	CA2219501A1 (de)
CZ (1)	CZ11698A3 (de)
DE (1)	DE69603968T2 (de)
DK (1)	DK0839036T3 (de)
ES (1)	ES2138359T3 (de)
GR (1)	GR3031096T3 (de)
HU (1)	HUP9802736A3 (de)
IL (1)	IL122302A (de)
IT (1)	IT1275532B (de)
NO (1)	NO980171D0 (de)
SK (1)	SK4198A3 (de)
WO (1)	WO1997003669A1 (de)
ZA (1)	ZA965924B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6852737B2 (en)	2001-08-06	2005-02-08	Recordati Ireland Limited	Crude and crystalline forms of lercanidipine hydrochloride
ITMI20011726A1 (it) *	2001-08-06	2003-02-06	Recordati Ind Chimica E Farma	Forme polimorfe della lercanidipina cloridrato
TW200613275A (en) *	2004-08-24	2006-05-01	Recordati Ireland Ltd	Lercanidipine salts
AR053023A1 (es) *	2005-02-25	2007-04-18	Recordati Ireland Ltd	Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
EA027787B1 (ru)	2010-06-23	2017-09-29	Крка, Товарна Здравил, Д.Д., Ново Место	Пероральные лекарственные формы, содержащие лерканидипин и эналаприл и их фармацевтически приемлемые соли
PL2627173T5 (pl)	2010-10-12	2019-11-29	Chiesi Farm Spa	Formulacje emulsyjne klewidypiny zawierające środki przeciw mikrobom
US8658676B2 (en)	2010-10-12	2014-02-25	The Medicines Company	Clevidipine emulsion formulations containing antimicrobial agents
WO2012085249A2 (en)	2010-12-24	2012-06-28	Krka, D.D., Novo Mesto	Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8403866D0 (en) *	1984-02-14	1984-03-21	Recordati Chem Pharm	Diphenylalkylaminoalkyl esters

1995
- 1995-07-14 IT ITMI951513A patent/IT1275532B/it active IP Right Grant
1996
- 1996-06-28 EP EP96924834A patent/EP0839036B1/de not_active Expired - Lifetime
- 1996-06-28 AU AU65164/96A patent/AU690471B2/en not_active Ceased
- 1996-06-28 HU HU9802736A patent/HUP9802736A3/hu unknown
- 1996-06-28 KR KR1019980700039A patent/KR19990028741A/ko not_active Withdrawn
- 1996-06-28 CA CA002219501A patent/CA2219501A1/en not_active Abandoned
- 1996-06-28 CZ CZ98116A patent/CZ11698A3/cs unknown
- 1996-06-28 IL IL12230296A patent/IL122302A/xx not_active IP Right Cessation
- 1996-06-28 CN CN96195439A patent/CN1190345A/zh active Pending
- 1996-06-28 DK DK96924834T patent/DK0839036T3/da active
- 1996-06-28 WO PCT/EP1996/002872 patent/WO1997003669A1/en not_active Ceased
- 1996-06-28 SK SK41-98A patent/SK4198A3/sk unknown
- 1996-06-28 ES ES96924834T patent/ES2138359T3/es not_active Expired - Lifetime
- 1996-06-28 DE DE69603968T patent/DE69603968T2/de not_active Expired - Fee Related
- 1996-06-28 JP JP9506222A patent/JPH11509214A/ja active Pending
- 1996-06-28 AT AT96924834T patent/ATE183644T1/de not_active IP Right Cessation
- 1996-07-12 ZA ZA965924A patent/ZA965924B/xx unknown
1998
- 1998-01-14 NO NO980171A patent/NO980171D0/no not_active Application Discontinuation
1999
- 1999-08-26 GR GR990402179T patent/GR3031096T3/el unknown

Also Published As

Publication number	Publication date
HUP9802736A3 (en)	2000-03-28
DE69603968T2 (de)	2000-04-06
EP0839036B1 (de)	1999-08-25
CA2219501A1 (en)	1997-02-06
ES2138359T3 (es)	2000-01-01
CN1190345A (zh)	1998-08-12
ZA965924B (en)	1997-01-30
HUP9802736A2 (hu)	1999-03-29
KR19990028741A (ko)	1999-04-15
SK4198A3 (en)	1998-05-06
WO1997003669A1 (en)	1997-02-06
DE69603968D1 (de)	1999-09-30
GR3031096T3 (en)	1999-12-31
IL122302A0 (en)	1998-04-05
CZ11698A3 (cs)	1998-06-17
IL122302A (en)	2000-08-13
NO980171L (no)	1998-01-14
IT1275532B (it)	1997-08-07
JPH11509214A (ja)	1999-08-17
ITMI951513A1 (it)	1997-01-14
DK0839036T3 (da)	2000-01-24
NO980171D0 (no)	1998-01-14
EP0839036A1 (de)	1998-05-06
AU6516496A (en)	1997-02-18
ITMI951513A0 (it)	1995-07-14
AU690471B2 (en)	1998-04-23

Similar Documents

Publication	Publication Date	Title
DE58909865D1 (de)	2000-02-10	Alkoxy-4(1h)-pyridon-derivative, verfahren zu deren herstellung und deren verwendung als arzneimittel
AR017639A1 (es)	2001-09-12	Procedimiento de la alquilacion directa en una etapa, en las posiciones 7 y 10 simultaneamente de las dos funciones hidroxilos de la 10-desacetilbacatina o de los derivados de esta ultima esterificados en la posicion 13.
EP0659211A4 (de)	1996-02-07	Verfahren und therapeutische zusammensetzungen zur behandlung von zystischer fibrose.
IE893123L (en)	1990-03-30	Use of gamma-interferon for the treatment of vascular¹stenosis
BR9509135A (pt)	1995-11-03	Processo para inibição da atividade do fator de tecido para inibição de depósito de plaquetas para inibição da restenose vascular e para tratamento de oclusão aguda de uma artéria coronária
EE9700153A (et)	1998-02-16	Heterotsükliga kondenseerunud püridiinid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
DE69015842D1 (de)	1995-02-23	Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE183644T1 (de)	1999-09-15	Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden
ATA900894A (de)	2001-04-15	Pharmazeutische kompositionen zum vorbeugen und heilen von krebserkrankungen und verfahren zu ihrer herstellung
ZA9610722B (en)	1997-06-27	Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
FR2753449B1 (fr)	1998-12-04	Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
DK0441279T3 (da)	1995-05-08	Bilobalid-phospholipid-komplekser, deres anvendelse og sammensætninger, der indeholder dem
DE69738320D1 (de)	2008-01-10	Verwendung von pyrolidin-derivaten zur herstellung von arzneimitteln zur behandlung von drogenmissbrauch
TW372962B (en)	1999-11-01	Pharmaceutical compositions for the prevention, arrest or reversal of atherosclerotic degradation in the arterial walls of a patient
NO974267D0 (no)	1997-09-16	Aminotetralinderivat for behandling av kardiovaskulære sykdommer
DE69011046D1 (de)	1994-09-01	Pyridinderivate, Verfahren zur Herstellung und pharmazeutische Zusammensetzungen.
FR2725720B1 (fr)	1997-01-03	Derives metalloceniques du diarylethylene, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits derives
EE9500055A (et)	1996-04-15	1,4-dihüdropüridiin-3,5-dikarboksüülhappeestrite kasutamine ravimitena, ravimid ja nende valmistamismeetod
ITMI932468A0 (it)	1993-11-22	Nuovi difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
FR2754256B1 (fr)	1998-12-24	Nouveaux derives 1,2-diarylmethylenes, leurs procedes de preparation, et leurs utilisations en therapeutique
ATE157670T1 (de)	1997-09-15	Digitoxigenin und dihydrodigitoxigenin 3-beta- derivate und pharmazeutische präparate davon, zur behandlung von hypertonie
AU2899099A (en)	1999-09-20	Composition for treatment and prevention of coronary artery disease
AU5817096A (en)	1996-11-29	Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
IT228470Y1 (it)	1998-02-19	Catetere per la disostruzione delle arterie
ITMI913512A0 (it)	1991-12-31	Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date	Code	Title
2000-03-15	EEIH	Change in the person of patent owner
2000-05-15	UEP	Publication of translation of european patent specification
2002-03-15	REN	Ceased due to non-payment of the annual fee